[Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN® gel stent and mitomycin C].
Mohammad Seleman BedarUlrich KellnerPublished in: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (2020)
The XEN® gel stent in combination with mitomycin C is a therapeutic option for difficult to adjust secondary glaucoma following intravitreal anti-VEGF therapy. A continuation of intravitreal anti-VEGF therapy did not lead to a recurrent increase of intraocular pressure.